Editorial
The Past and Future of Organ Transplantation I t has now been thirty years since the burger and some of the other European first attempt was made a t renal homo-authorities. transplantation in man. The early efforts
In spite of the occasional encouraging to apply this form of therapy to the treat-experience, the prospect oi achieving sigment of terminal renal disease were doomed nificant clinical benefit from renal homoto failure since they preceded an apprecia-transplantation in more than the isolated tion oi the problems to be encountered. case seemed remote indeed until the Knolvledqe oi homo,qait rejection was discox-ery by Schrvartz and Dameshek scanty. and the therapy necessary to pre-of the immunosuppressive properties of vent this process was not understood at all. 6-mercaptopurine in 1959 and the subseSince that time, a rational explanation oi quent testing of this drug and its analogue, rejection has been provided by the studies Azathioprine, by Calne and Zukoski. I t of bIedawar and those of other investi-immediately became apparent that prevengators. The evidence is overwhelming tion of homograft rejection could be that rejection is due to immunologic accomplished with greater regularity and repudiation of the alien tissue by the host. with less risk to the recipient than had The intensity of this reaction is related to been possible with total-body irradiation: the degree ol' genetic dissimilarity between long-term homograft viability was achieved the donor and the recipient. Its preven-in animals without the necessity oi contion depends to a greater or less extent comitant host leukopenia or agranulocytoupon crippling the host's capacity for sis. During the ensuing several years, immunologic response to unfamiliar anti-clinical efforts a t homotransplantation of gens.
the kidney have proceeded with increasing The initial attempts at potentiating regularity. By Sept. 13, 1964, almost 500 homo,grait function by alteration of the such potentially therapeutic operations host were made with total-body irradiation. were known, by virtue of their entry into Such therapy proved to be of value for the the Sational Academy of Science Registry, prevention of rejection, but the requisite to have been performed throughout the dosage was so high that most of the re-world. cipient patients died from bone-marrow ,
The experience with clinical renal homodepression and sepsis. Despite the ex-transplantation resulted in a number of orbitant risk imposed, 3 patients are still significant observations which had not been living irom this pioneer era, the longest appreciated from animal studies. I t had follow-up being on a young man treated long been assumed that rejection was one almost six years ago by Murray and of nature's most powerful and persevering Slerrill ~vith a homograft from his fraternal reactions, which was inexorable when twin. Today, American centers do not once begun. I t was soon learned that generally use total-body irradiation, al-rejection was a reversible process and, though it remains an important element more recently, evidence has accrued that it in the overall therapy employed by Ham-occasionally runs a spontaneously re-;S(iY mittent course. Al~though the cl~nical of little value for potentiation of homograft manifestations of rejection could be survival, but in-combination with kzaavoided in only a minority of cases, the thioprine, they play a crucial role in the adverse effects could be mitigated and mitication and reversal of an established -reversed in most instances.
rejection. Secondary adjuvants which In the majority of centers the most im-have been useiul are actinomycin C and portant immunosuppressive agent used is .lzathioprine. This drug, which inhibits nucleic acid synthesis, is started before or a t the time of transplantation and continued indefinitely thereafter : it is a potentially dangerous agent since bone-marrow depression results from overdosage, and even in small quantities it local homograft irradiation.
The effectiveness of local homograf t irradiation for the prevention and treatment of rejection was established by the work of Hume and Goodwin and their associates. The explanation of the therapeutic benefit is not known. During a rejection crisis, the kidney is infiltrated may be hepatotoxic. ~rednisone is also with cells and enlarges; the transplant essential. When used alone, steroids arc wound becomes tender. After the first dose oi 1.JO R ( a t depth), t l~e 1oc:il signs grafts irom xenetically rclated donors were are oitCn tlramaticallv relieved, and soon used: two-thirds oi all those patients who ,,iter there is frequently an impro\-ement received kidneys from 1)lood relatives are in the deteriorated renal function. Or-still living : r Fig. 1 1. With unrelated donors dinarily, the dose is repeated on three the results are poor sin( only one-third alternate days for a total of 4,50 R. Fur-lived for as long as one dr (Fig. 1) . In ther investiqations are needed concerning our experience the l~est survival within the mechanism of this effect. In addition, the related group was ~vith parent-tomore precise knowledge is required of the oiTsprin transplants. 71) per cent oi t l~e potential irradiation injury to the Iiomo-recipients still bein: alive i Fig. 21 . In graft which may be the penalty ior this the world experience, sibling-to-sibling short-term benefit.
transiers have had the highest success Imperfect though the currently em-rate.
PARENTAL DONOR AUNT, UNCLE, ployed therapeutic methods are, greatly
These results indicate that many uremic improved earlv survival after renal homo-patients, perhaps even the majority, can be transplantation has been reported from materially benefited by renal homotransseveral centers, and it has already become plantation with relatively complete social possible to state with relative certainty and vocational rehabilitation over conthat homotransplantation will have an siderable periods of time. Severtheless, increasing role in the general medical workers in the field who have repeatedly armamentarium of the future. The re-warned that this treatment is experimental sults with recent clinical experience have are not yet willing to abandon this position. exceeded any hopes of even a few years The most important reason for a conservaago. Of the first 64 patients treated tive attitude is that the ultimate life exat the University of Colorado lledical pectancy of the present crop of chronic Center with kidneys from volunteer living survivors is still unknown. Barnes has donors, 37 homograft recipients lived for attempted to answer this question with at least one year after operation (Fig. 1 ) a statistical analysis of the death rate of and 36 are still alive from thirteen to those patients already treated and has twenty-nine months (mean nineteen predicted that further losses from that months). IVithin this time limit, the group of patients still living will occur a t results approach acceptability if homo-an extremelv gradual rate. \\liethcr this is true or not can he de-I)e required to studv tliese and many othcr termined only by actual observation. In important problems. the Incantime there is le~gitimate reason 'The potential applicability oi nti\ lnces lor avoiding overoptimism. S o t all pa-in homotransplantation is, of course, not ticnts who have reached a chronic stage of limited to the field of renal disease. In ~,ouvalescence are well. In many, there is future years, it seems inevitable that other c\-itiencc oi continued host-aqainst-grait kinds of mono-organ failure will be treated Irnrnur~oioqic activity rnarliiested in some with functional liomografts. -llready, at-C L I S~S i)]i. acute episodes of late rejection. in tempts have been made in man to transotllers by histo10,qic evidence oi active plant the heart, lung, and liver. X1-rejection despite perfectly functioning though protracted survival has yet to be llomoqraits, and in still others bv a slow obtained in man with any of these organs, and insidious deterioration of function. I t the difficulties encountered have not seemed is possible that most of the apparently well inherently insolvable. Survival of a year patients are living by virtue of renal or longer has been accomplished in dogs 11omo:rafts which are losing a small frac-with all three types of homograits, and tion oi functioning parenchyma each day. with livers the regularity with which For the moment, therefore, it would seem long-tern1 success can be achiel-ed equals most reasonable to regard renal homo-that reported with canine kidneys. 'These transplantation as an ehective, but in-findings suggest that strong organ-specific completely characterized, form of palliative antigens will not make the control oi therapy. Ultimately it mav be proved rejection more difficult and that the to 11e a curative procedure, but that time immunosuppressive methods mill have an lias not yet arrived.
interchangeable efficacy with different -1cceptance that human renal homo-homotransplanted tissues. This is not transplantation is still an exercise in to imply that success will be as readily clinical investigation may slow the wide-attainable as with kidneys. The probspread use of this procedure and hopefully lems of surgical technic are more forconfine its application to appropriately midable. Special physiologic problems quipped institutions in ~vhich the clinical concerning denervation and blood supply program is only one component of an have been encountered. The necessity overall transplantation effort.
Under for use of cadaveric organs limitsboth the these circumstances, potentially significant quantity and quality of supply. Finally, discoveries in the animal laboratories can the secondary illness and deterioration t,e tested on the wards with a minimum of homograft function during a potentially delay : conversely, observations on pa-reversible rejection of such organs may tients will influence the direction of basic carry a far more serious implication than research.
with the kidney, since effective estra-'To illustrate the interdisciplinaq na-corporeal hearts, livers, and lungs have not cure oi the undertaking, one need only reached the stage of perfection which to mention the necessity of identifying would allow their emergency use for several iluman histocompatibilitv antigens for days or weeks during a postoperative improvement of future donor-recipient rejection episode. 
